291 related articles for article (PubMed ID: 18621429)
21. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
22. Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan.
Griffiths UK; Wolfson LJ; Quddus A; Younus M; Hafiz RA
Bull World Health Organ; 2004 Sep; 82(9):643-51. PubMed ID: 15628201
[TBL] [Abstract][Full Text] [Related]
23. [The analysis of refractive error in children and adolescents from 6-15 years of age based on 1000 examinations in two major Polish regions].
Szaflik J; Prost M; Zaleska-Zmijewska A; Hapunik A; Wójcik A
Klin Oczna; 2004; 106(3 Suppl):471-3. PubMed ID: 15636240
[TBL] [Abstract][Full Text] [Related]
24. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?
Anderson R; Haas M; Shanahan M
Aust N Z J Public Health; 2008 Feb; 32(1):43-52. PubMed ID: 18290913
[TBL] [Abstract][Full Text] [Related]
25. Costs associated with ventricular assist device use in children.
Mahle WT; Ianucci G; Vincent RN; Kanter KR
Ann Thorac Surg; 2008 Nov; 86(5):1592-7. PubMed ID: 19049755
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.
Chisholm D;
Epilepsia; 2005 May; 46(5):751-9. PubMed ID: 15857443
[TBL] [Abstract][Full Text] [Related]
27. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.
Atherly D; Dreibelbis R; Parashar UD; Levin C; Wecker J; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S28-38. PubMed ID: 19817610
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with spectacle-wear compliance in school-aged Mexican children.
Castanon Holguin AM; Congdon N; Patel N; Ratcliffe A; Esteso P; Toledo Flores S; Gilbert D; Pereyra Rito MA; Munoz B
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):925-8. PubMed ID: 16505025
[TBL] [Abstract][Full Text] [Related]
29. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
Goldstein JA; Winston FK; Kallan MJ; Branas CC; Schwartz JS
Ambul Pediatr; 2008; 8(1):58-65. PubMed ID: 18191783
[TBL] [Abstract][Full Text] [Related]
30. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.
Hogan DR; Baltussen R; Hayashi C; Lauer JA; Salomon JA
BMJ; 2005 Dec; 331(7530):1431-7. PubMed ID: 16282380
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
Flaherman VJ; Porco TC; Marseille E; Royce SE
Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy.
Giorgi-Rossi P; Merito M; Borgia P
Health Policy; 2009 Feb; 89(2):225-38. PubMed ID: 18639952
[TBL] [Abstract][Full Text] [Related]
33. The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel.
Marseille E; Lohse N; Jiwani A; Hod M; Seshiah V; Yajnik CS; Arora GP; Balaji V; Henriksen O; Lieberman N; Chen R; Damm P; Metzger BE; Kahn JG
J Matern Fetal Neonatal Med; 2013 May; 26(8):802-10. PubMed ID: 23311860
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti.
Suaya JA; Shepard DS; Chang MS; Caram M; Hoyer S; Socheat D; Chantha N; Nathan MB
Trop Med Int Health; 2007 Sep; 12(9):1026-36. PubMed ID: 17875014
[TBL] [Abstract][Full Text] [Related]
35. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
[TBL] [Abstract][Full Text] [Related]
36. Economic evaluation of tandem mass spectrometry newborn screening in Australia.
Norman R; Haas M; Chaplin M; Joy P; Wilcken B
Pediatrics; 2009 Feb; 123(2):451-7. PubMed ID: 19171609
[TBL] [Abstract][Full Text] [Related]
37. Simulating cost-effectiveness of fluoride varnish during well-child visits for Medicaid-enrolled children.
Quiñonez RB; Stearns SC; Talekar BS; Rozier RG; Downs SM
Arch Pediatr Adolesc Med; 2006 Feb; 160(2):164-70. PubMed ID: 16461872
[TBL] [Abstract][Full Text] [Related]
38. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
39. The cost-effectiveness of public postsecondary education subsidies.
Muennig P; Fahs M
Prev Med; 2001 Feb; 32(2):156-62. PubMed ID: 11162341
[TBL] [Abstract][Full Text] [Related]
40. Volume of alcohol consumption, patterns of drinking and burden of disease in the European region 2002.
Rehm J; Taylor B; Patra J
Addiction; 2006 Aug; 101(8):1086-95. PubMed ID: 16869838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
